[go: up one dir, main page]

EA200300532A1 - Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке - Google Patents

Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке

Info

Publication number
EA200300532A1
EA200300532A1 EA200300532A EA200300532A EA200300532A1 EA 200300532 A1 EA200300532 A1 EA 200300532A1 EA 200300532 A EA200300532 A EA 200300532A EA 200300532 A EA200300532 A EA 200300532A EA 200300532 A1 EA200300532 A1 EA 200300532A1
Authority
EA
Eurasian Patent Office
Prior art keywords
acetaldehyde
saliva
stomach
binding
composition
Prior art date
Application number
EA200300532A
Other languages
English (en)
Other versions
EA009335B1 (ru
Inventor
Микко Саласпуро
Марти Марвола
Original Assignee
Биохит Оий
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биохит Оий filed Critical Биохит Оий
Publication of EA200300532A1 publication Critical patent/EA200300532A1/ru
Publication of EA009335B1 publication Critical patent/EA009335B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Задачей изобретения является применение соединений, содержащих один или несколько свободных сульфгидрилов или аминогрупп, для получения фармацевтического состава для локального связывания ацетальдегида в слюне, желудке или толстой кишке, и фармацевтических составов, содержащих указанные соединения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300532A 2000-10-30 2001-10-30 Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке EA009335B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20002392A FI121528B (fi) 2000-10-30 2000-10-30 Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
PCT/FI2001/000948 WO2002036098A1 (en) 2000-10-30 2001-10-30 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine

Publications (2)

Publication Number Publication Date
EA200300532A1 true EA200300532A1 (ru) 2003-10-30
EA009335B1 EA009335B1 (ru) 2007-12-28

Family

ID=8559405

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300532A EA009335B1 (ru) 2000-10-30 2001-10-30 Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке

Country Status (10)

Country Link
US (1) US9474733B2 (ru)
EP (1) EP1339394B1 (ru)
JP (1) JP4691312B2 (ru)
CN (1) CN100467016C (ru)
AT (1) ATE522203T1 (ru)
AU (1) AU2002212395A1 (ru)
EA (1) EA009335B1 (ru)
ES (1) ES2370811T3 (ru)
FI (1) FI121528B (ru)
WO (1) WO2002036098A1 (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI121528B (fi) 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
MXPA03004546A (es) 2000-11-22 2003-09-10 Rxkinetix Inc Tratamiento de mucositis.
JP5654726B2 (ja) * 2004-10-08 2015-01-14 ビオヒット・ユルキネン・オサケユキテュアＢｉｏｈｉｔ Ｏｙｊ 唾液中のアルデヒド類を結合するための方法および製剤
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
FI122914B (fi) * 2005-04-01 2012-08-31 Biohit Oyj Elintarvikekoostumus asetaldehydin sitomiseksi suussa ja ruoansulatuskanavassa ja menetelmä koostumuksen valmistamiseksi
CA2615319A1 (en) * 2005-07-13 2007-01-18 Al Czap Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof
WO2007064755A2 (en) 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
US20100166833A1 (en) * 2007-05-07 2010-07-01 Technion Research & Development Foundation Ltd. Compositions, articles and methods for preventing or reducing tobacco-associated damage
FI120526B (fi) * 2007-05-16 2009-11-30 Biohit Oyj Filtteri tupakkatuotteeseen
FI20070705L (fi) * 2007-09-14 2009-06-02 Biohit Oyj Asetaldehydin sitominen suussa ja mahalaukussa
US20090092664A1 (en) * 2007-10-08 2009-04-09 University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
IL188681A0 (en) 2008-01-09 2008-12-29 Amino Acid Solutions Inc Pharmaceutical compositions and methods utilizing a d-amino acid
FI20115680L (fi) * 2011-06-29 2012-12-30 Biohit Oyj Nestemäisiä farmaseuttisia koostumuksia tai yhdistelmätuotteita
FI129157B (en) * 2012-05-28 2021-08-13 Biohit Oyj Composition for use in reducing the incidence of or preventing severe headaches
FI20135097A7 (fi) * 2013-02-01 2014-08-02 Biohit Oyj Koostumus aldehydien sitomiseen suussa
CA2905187A1 (en) 2013-03-12 2014-09-18 Biohit Oyj Encapsulated composition for binding aldehydes in the stomach
WO2014140410A1 (en) 2013-03-12 2014-09-18 Biohit Oyj Composition for oral administration for binding aldehydes in the gastrointestinal tract
FI20145217A7 (fi) 2014-03-06 2015-09-07 Biohit Oyj Koostumus aldehydien ja vapaiden radikaalien sitomiseksi ruoansulatuskanavassa
CN108671232A (zh) * 2018-07-09 2018-10-19 珠海中科先进技术研究院有限公司 一种能够降低体内乙醛浓度的组合制剂及其制备方法与用途
WO2020187712A1 (en) 2019-03-15 2020-09-24 Novo Nordisk A/S Process for spray drying a glp-1 peptide
US11717554B2 (en) * 2019-09-19 2023-08-08 Max R&D Llc Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)
CN119214993A (zh) * 2024-09-27 2024-12-31 国家纳米科学中心 用于清除醛基的透明质酸纳米凝胶、其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0054795B1 (en) * 1980-12-09 1987-07-15 Teijin Limited Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
US4496548A (en) 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
GB8313044D0 (en) 1983-05-12 1983-06-15 Caseley J R Reducing toxic effects of tobacco
US4528295A (en) * 1983-08-15 1985-07-09 Boris Tabakoff Composition and method for reducing blood acetaldehyde levels
JPS6116144A (ja) 1984-06-29 1986-01-24 Fujitsu Ten Ltd 異常シフト警報装置
US5202354A (en) * 1986-02-18 1993-04-13 Takeda Chemical Industries, Ltd. Composition and method for reducing acetaldehyde toxicity
PH22818A (en) * 1986-02-18 1989-01-19 Takeda Chemical Industries Ltd Composition and method for reducing acetaldehyde toxicity
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
CH674148A5 (ru) * 1986-06-24 1990-05-15 Racz Istvan
EP0265061B1 (en) * 1986-09-18 1992-01-08 London School of Pharmacy Innovations Ltd Pharmaceutical formulation
HU201865B (en) 1989-04-28 1991-01-28 Pecsi Dohanygyar Tobacco-smoke filter of high efficiency
JPH0374327A (ja) * 1989-08-16 1991-03-28 Ajinomoto Co Inc アルコール代謝促進剤
JPH03136895A (ja) 1989-10-23 1991-06-11 Fuji Electric Co Ltd 光情報記録媒体の製造方法
JPH0421635A (ja) 1990-05-16 1992-01-24 Suntory Ltd アセトアルデヒドの毒性抑制剤およびアセトアルデヒドの毒性抑制に有効な飲食物
US5110423A (en) * 1990-05-25 1992-05-05 Technic Inc. Bath for electroplating bright tin or tin-lead alloys and method thereof
JP3013860B2 (ja) 1991-03-22 2000-02-28 三菱瓦斯化学株式会社 食品保存剤およびこれを用いた食品の保存方法
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
JP3479986B2 (ja) 1992-10-07 2003-12-15 大正製薬株式会社 アルコール性肝障害予防用組成物
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
JPH09194361A (ja) * 1996-01-19 1997-07-29 Wakunaga Pharmaceut Co Ltd 抗腫瘍剤
AU6471696A (en) * 1996-07-22 1998-02-10 Kouki Bussan Yugenkaisha Novel adsorbent
US5829449A (en) 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
IN186245B (ru) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US5922346A (en) 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
WO2000071145A1 (en) 1999-05-24 2000-11-30 Hee Jung Kim Composition for recovering from a hangover and for preventing brain cell damage
CA2386954C (en) * 1999-10-29 2011-12-13 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
FI121528B (fi) 2000-10-30 2010-12-31 Biohit Oyj Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa
ITPI20010014A1 (it) 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
WO2002098405A1 (fr) 2001-06-05 2002-12-12 Ajinomoto Co., Inc. Inhibiteurs de fibrose du foie
JP2003055215A (ja) 2001-06-05 2003-02-26 Ajinomoto Co Inc 肝線維化抑制剤
US6936283B2 (en) * 2003-07-25 2005-08-30 Langeland Bjoern T. Composition for stimulation of specific metallo-enzymes
KR20070034459A (ko) 2004-02-17 2007-03-28 마르쿠스 그라프 폰 마투시카-그라이펜클라우 알콜 대사 조절 조성물

Also Published As

Publication number Publication date
EA009335B1 (ru) 2007-12-28
CN1486177A (zh) 2004-03-31
FI20002392L (fi) 2002-05-01
WO2002036098A1 (en) 2002-05-10
ATE522203T1 (de) 2011-09-15
JP4691312B2 (ja) 2011-06-01
FI20002392A0 (fi) 2000-10-30
US9474733B2 (en) 2016-10-25
CN100467016C (zh) 2009-03-11
JP2004512353A (ja) 2004-04-22
ES2370811T3 (es) 2011-12-23
AU2002212395A1 (en) 2002-05-15
EP1339394B1 (en) 2011-08-31
US20050267042A1 (en) 2005-12-01
EP1339394A1 (en) 2003-09-03
FI121528B (fi) 2010-12-31

Similar Documents

Publication Publication Date Title
EA200300532A1 (ru) Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
EA200200940A1 (ru) Производные азетидина, способ их получения и содержащие их фармацевтические композиции
BR0112969A (pt) Método de utilização de dicetopiperazinas e composições contendo-as
EA200500453A1 (ru) Имидазопиридины и способы их получения и применения
NL300877I2 (nl) obeticholzuur
EA200300580A1 (ru) Соединения лактама
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
EA200400067A1 (ru) Конъюгаты гксф
DK2014304T3 (da) Kolonrensende sammensætninger
EA200301159A1 (ru) Цитотоксические иммуноконъюгаты антитела к cd44
EA199900373A2 (ru) Фармацевтические композиции
IS6658A (is) Ný efnasambönd
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
EA200300050A1 (ru) Гликопептидфосфонатные производные
ATE494884T1 (de) Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält
HUT77925A (hu) Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DE60219005D1 (de) Feste pharmazeutische formulierung enthaltend modafinil
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0203825D0 (sv) Novel fused heterocycles and uses thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM

MK4A Patent expired

Designated state(s): AZ BY KZ RU